+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Susceptibility in urinary bladder cancer acetyltransferase phenotypes and related risk factors



Susceptibility in urinary bladder cancer acetyltransferase phenotypes and related risk factors



Cancer Letters 32(2): 199-206



The excess proportion of slow acetylator phenotypes has previously been found among bladder tumour patients. Among 228 bladder tumour patients in the present study, the slow acetylator phenotype was significantly associated to the unskilled worker and T3-T4 tumour, and to a certain extent to tobacco smoking. It is suggested that slow acetylator subjects are more susceptible to bladder tumour development when exposed to arylamines.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 006552986

Download citation: RISBibTeXText

PMID: 3756846

DOI: 10.1016/0304-3835(86)90120-5


Related references

Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Archives of Toxicology 87(12): 2129-2139, 2013

N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population. Carcinogenesis 6(2): 199-201, 1985

N-acetyltransferase phenotypes of bladder cancer patients in a low-risk population. Lancet 2(8309): 1228, 1982

Bladder carcinogenesis and ecogenetics: A study on the role of N-acetyltransferase polymorphism and various risk factors in bladder cancer. Journal of Cancer Research and Clinical Oncology 111(1 Suppl.): S140-0, 1986

Highlight report: N-acetyltransferase 2 and urinary bladder cancer risk. Archives of Toxicology, 2017

N-acetyltransferase slow acetylator phenotype increases susceptibility to occupational related aggressive bladder cancer. Proceedings of the American Association for Cancer Research Annual Meeting 36: 121, 1995

Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk. Journal of Applied Genetics 42(2): 223-231, 2001

N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population. Journal of Oncology 2012: 512976, 2012

N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25(11): 1649-1658, 2006

Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2(8303): 842-845, 1982

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. British Journal of Cancer 81(3): 537-541, 1999

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives 29: 71-79, 1979

Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese. Urological Research 29(3): 199-204, 2001

Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicology Letters 193(2): 131-137, 2010

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79. International Journal of Epidemiology 36(1): 11-18, 2007